Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
55.69
+0.93 (1.70%)
May 11, 2026, 3:04 PM CST

SHE:002653 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,8101,3861,0561,169775.39575.11
Trading Asset Securities
130-150.13160.06--
Cash & Short-Term Investments
1,9401,3861,2061,329775.39575.11
Cash Growth
49.46%14.94%-9.23%71.37%34.82%-53.41%
Accounts Receivable
892.131,0331,077883.9803.79569.97
Other Receivables
26.9325.3340.3546.7947.1478.5
Receivables
919.061,0581,117930.69850.93648.47
Inventory
328.46306.77271.61281.29346259.95
Prepaid Expenses
-10.0922.55---
Other Current Assets
68.7172.87112.53100.0281.3264.9
Total Current Assets
3,2562,8342,7302,6412,0541,548
Property, Plant & Equipment
854.43853.21917.09996.041,0741,137
Long-Term Investments
426.58177.99146.99232.46422.17381.19
Other Intangible Assets
1,4741,5181,277751.23708.33682.47
Long-Term Deferred Tax Assets
173.52204.7177.23148.24126.0883.57
Long-Term Deferred Charges
1,003957.531,1071,4271,233822.42
Other Long-Term Assets
471.25465.62443.95457.37430.15350.51
Total Assets
7,6607,0116,7986,6536,0485,005
Accounts Payable
156.54165.85195.89208.99242.44301.4
Accrued Expenses
83.66261.19190.48200.09136.68120.63
Short-Term Debt
27.2279.95242.5799.98484.69452.18
Current Portion of Long-Term Debt
1,152880.74728.41833.59295.4325.78
Current Portion of Leases
-7.8410.277.416.648
Current Income Taxes Payable
47.128.925.4916.0816.11.71
Current Unearned Revenue
15.0116.7220.8714.6126.9628.44
Other Current Liabilities
133.81146.03174.23123.23279.64279.98
Total Current Liabilities
1,6151,5671,5681,5041,4891,518
Long-Term Debt
1,0361,002925854.681,320452.41
Long-Term Leases
22.339.554.1410.854.5210.91
Long-Term Unearned Revenue
134.53134.7795.06108.4798.52102.54
Long-Term Deferred Tax Liabilities
9.769.623.774.012.531.11
Other Long-Term Liabilities
---0.38--
Total Liabilities
2,8172,7232,5962,4822,9142,085
Common Stock
1,1201,1201,1201,1141,0761,077
Additional Paid-In Capital
1,0931,085953.57853.38100.8297.62
Retained Earnings
2,6902,1362,1802,2101,8071,733
Treasury Stock
-56.66-56.66-80.94-9.15-24.44-38.31
Comprehensive Income & Other
-1.865.7740.5511.8676.41-26.82
Total Common Equity
4,8444,2904,2134,1803,0362,842
Minority Interest
-2.01-2-11.09-9.3697.6878.27
Shareholders' Equity
4,8424,2884,2024,1713,1332,920
Total Liabilities & Equity
7,6607,0116,7986,6536,0485,005
Total Debt
2,2371,9801,9101,8072,1111,249
Net Cash (Debt)
-296.6-593.2-704.22-477.74-1,336-674.16
Net Cash Per Share
-0.27-0.53-0.62-0.44-1.25-0.63
Filing Date Shares Outstanding
1,1091,1551,1591,0481,0361,091
Total Common Shares Outstanding
1,1091,1551,1591,0481,0361,091
Working Capital
1,6411,2671,1621,137565.0930.32
Book Value Per Share
4.373.713.633.992.932.61
Tangible Book Value
3,3702,7722,9373,4292,3272,159
Tangible Book Value Per Share
3.042.402.533.272.251.98
Buildings
-930.28931.33965.52922.14931.62
Machinery
-818.33789.01748.62709.94677.15
Construction In Progress
-0.66.735.8797.988.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.